Cargando…
Third dose corrects waning immunity to SARS-CoV-2 mRNA vaccines in immunocompromised patients with immune-mediated inflammatory diseases
Autores principales: | Cheung, Michelle W, Dayam, Roya M, Law, Jaclyn C, Goetgebuer, Rogier L, Chao, Gary Y C, Finkelstein, Naomi, Stempak, Joanne M, Pereira, Daniel, Croitoru, David, Acheampong, Lily, Rizwan, Saima, Lee, Jenny D, Ganatra, Darshini, Law, Ryan, Delgado-Brand, Melanie, Mailhot, Geneviève, Piguet, Vincent, Silverberg, Mark S, Watts, Tania H, Gingras, Anne-Claude, Chandran, Vinod |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471210/ http://dx.doi.org/10.1136/rmdopen-2022-002622 |
Ejemplares similares
-
Tu1548: IMMUNE RESPONSE AFTER COVID-19 VACCINATION DURING MAINTANACE THERAPY IN IMMUNE-MEDIATED INFLAMMATORY DISEASES: AN OBSERVATIONAL COHORT STUDY
por: Dayam, R.M., et al.
Publicado: (2022) -
Waning and boosting: on the dynamics of immune status
por: Diekmann, O., et al.
Publicado: (2018) -
Modelling optimal lockdowns with waning immunity
por: Goenka, Aditya, et al.
Publicado: (2022) -
Paradoxical reactions under TNF-α blocking agents and other biological agents given for chronic immune-mediated diseases: an analytical and comprehensive overview
por: Toussirot, Éric, et al.
Publicado: (2016) -
Is methotrexate safe for men with an immune-mediated inflammatory disease and an active desire to become a father? Results of a prospective cohort study (iFAME-MTX)
por: Perez-Garcia, Luis Fernando, et al.
Publicado: (2023)